223
Participants
Start Date
December 31, 2007
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Drug: YAZ flex (SH T00186D)
Extended flexible regimen of YAZ (SH T00186D); triggered by bleeding events(Tablet p.o. (oral))
YAZ (SH T00186D)
YAZ (SH T 00186D) administered in the conventional regimen (24 days active + 4 days placebo) (Tablet p.o. (oral))
Berlin
Berlin
Berlin
Berlin
Hanover
Hanover
Fulda
Blankenburg
Magdeburg
Magdeburg
Magdeburg
Burg
Frankfurt am Main
Mühlheim am Main
Heidelberg
Nuremberg
Leipzig
Leipzig
Leipzig
Wurzen
Bernburg
Jessen
Gera
Kahla
Chesterfield
Newcastle upon Tyne
London
Lead Sponsor
Bayer
INDUSTRY